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Comparisons of human/rat species variants of 23 dehydrogenases versus 41 entries for peptide hormones and 41 for proteasesfantiproteases r veal 
characteristic patterns. Dehydrogenases are ‘constant’ (2-88 residue differences between homologues) or ‘variable’ (1240% differences). Peptide 
hormones exhibit a wider range, with many ‘strictly conserved’ and others spreading upscale, while proteases/antiproteases are overall shifted 
upscale, with few ‘constant’ and many ‘variable’. Overall, the influence of polypeptide size and function is confirmed, while for the dehydrogenases, 
the data highlight the ‘constant’ pattern as the one with high frequency values and suggest for classic liver alcohol dehydrogenase the ‘variable’ 
pattern to correlate with emerging functions. 
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1. INTRODUCTION 
Evolutionary changes in proteins differ by large fac- 
tors, reflecting structural and functional properties of 
the molecules [l-3]. Within certain limits, the value for 
each protein is fairly constant over extensive periods, as 
long as overall functional properties are unaltered. 
Therefore, the rate of change constitutes a useful pa- 
rameter in judging both protein function [l-4] and those 
few deviations that might indicate wide inter-species 
gene transfer [5]. 
Many dehydrogenases, however, appear to follow ei- 
ther of two separate volutionary lines, being ‘constant’ 
or ‘variable’, with such a split also between related 
forms with seemingly similar properties [6]. For evalua- 
tion of which of the dehydrogenase patterns that is typ- 
ical at large, and what the split may mean, comparisons 
with the patterns for other proteins are of interest. We 
have now evaluated the pattern for characterized 
human/rat dehydrogenases versus those for proteins 
with strict interactions (peptide hormones) or less strict 
specificities (proteases/antiproteases). Results reveal 
distinct patterns, emphasizing unique properties from 
which further conclusions can be drawn. 
2. MATERIALS AND METHODS 
Primary structures of pyridine-nucleotide linked dehydrogenases, 
proteases/antiproteases, and peptide hormones for which correspond- 
ing human and rat variants are known were extracted from the Swiss- 
Prot data base [7]. Some incomplete structures from another source 
were also included [8]. Because of nomenclature problems, a few pro- 
teins may have been missed, and some inclusions are questionable. In 
the case of multi-chain native molecules, the functional activity need 
not always be associated with the chain(s) available, and for some of 
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the bioactive peptides or binding proteins inclusions in the hormonal 
group may be unclear. However, considering the patterns observed, 
single missing or extra entries do not affect the conclusions. In calcu- 
lations of residue differences, gap positions are counted, but in assign- 
ments of total size they are not. When the sizes of the human/rat 
homologues differ, the longest variant is the one listed and used in the 
calculation of relative differences. For native molecules with more 
than one type of chain, chains are listed separately when separate 
functions are defined (as for most hormones) but otherwise often 
combined (as for most proteases/antiproteases). In all cases, attempts 
have been made to remove signal sequences and large parts eliminated 
during processing, such that the entries reflect the mature forms. 
Especially for the hormones, differently processed forms exist, in 
which cases one of the common forms has been chosen for compari- 
sons. Also, for many of the structures, conflicting reports or variants 
affecting single positions exist, in which case the structure used is the 
one from the main entry. 
3. RESULTS AND DISCUSSION 
Analysis of available structures for species variants of 
corresponding proteins in the SwissProt data base [7] 
identified 23 pairs of dehydrogenases characterized 
both in the human and rat forms (Table I), 41 pairs of 
entries for peptide hormones (Table II), and 41 pairs of 
entries for proteases/antiproteases (Table III). As stated 
above, single proteins may have been missed because 
nomenclature is not always easy to follow. Also, a few 
entries had to be eliminated because of multiple reports 
or other interpretational difficulties. The spreads of var- 
iability reveal distinct patterns as shown in Fig. 1. They 
have features in common, reflecting general properties 
of proteins, but also characteristic differences. 
3.1. Patterns for different proteins 
3.1.1. Dehydrogenases 
Many dehydrogenase structures are centred in the 
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‘constant’ region, with a variability between the species 
in the order of about 6%, but also with a spread upscale, 
constituting ‘variable’ dehydrogenases (Fig. 1). Obvi- 
ously, this overall pattern constitutes the explanation to 
the presence of two types of variability observed in some 
dehydrogenases [6]. The two types are concluded to 
reflect differences in functional restrictions on the struc- 
tures, and the results now show that the ‘constant’ dehy- 
drogenase pattern is the one with many representatives 
closely assembled at about the same value (Fig. 1). 
Overall, the distribution of the dehydrogenases is 
shifted to the left in relation to those of the other two 
protein classes (Fig. 1). Since polypeptide chain length 
is one factor limiting structural variability [l], this prob- 
ably reflects just the fact that dehydrogenases on the 
average have longer polypeptide chains than most pep- 
tide hormones and proteases/antiproteases. 
3.1.2. Peptide hormones 
Their pattern is clearly distributed into all variability 
groups. Close to one third (13 of 41) are ‘strictly con- 
served’, exhibiting no variability between the species, 
somewhat fewer are within the ‘constant’ group, while 
the remaining forms are widely distributed, constituting 
‘variable’ or even ‘hyper-variable’ structures. 
The general right-shift of the ‘variable’ hormones ver- 
sus the ‘variable’ dehydrogenases probably just reflects 
the different sizes. However, the ‘constant’ hormones, 
at about the same variability level as the ‘constant’ de- 
hydrogenases, are concluded to reflect restrictions from 
the functional properties, probably the importance of 
the receptor binding requirements. In spite of the small 
sizes of several peptide hormones, the multiple interac- 
tions inherent in receptor binding apparently restrict 
many forms, securing the selective hormone responses. 
3.1.3. Proteases/antiproteases 
This pattern is clearly different from those for the 
other two protein types, and most proteases/antipro- 
teases characterized fall in the ‘variable’ group, proba- 
bly reflecting the fact that the hydrolase reaction is non- 
complicated, not requiring coenzymes, and with often 
wide substrate specificities. 
3.2. Different conservation groups 
Three types of variability are apparent. A pattern of 
strict conservation between the human/rat protein 
forms is exhibited by many peptide hormones, the ma- 
jority of which are fairly short (Table II), with limited 
elements of tertiary structure. Hence, as concluded 
above, it must reflect stringent needs for functional in- 
teractions, limiting the variability. 
A constant pattern, at a low level of variability (2- 
11%) appears to be the one typical of many dehydroge- 
nases, and also represented by the peptide hormones 
and a few of the proteases/antiproteases. Apparently, 
this is a variability level that constitutes a common 
background level of both large and small peptides. 
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Table I 
Characterized structural differences between corresponding forms of 
human/rat dehydrogenases 
Protein Length Gaps Differences 
(residues) (posi- 
tions) (number) (per cent) 
- 
Alcohol DH class I 
Alcohol DH class II 
(fragments) 
Alcohol DH class III 
Alcohol DH class IV 
(fragments) 
Aldehyde DH, cytosolic 
Aldehyde DH, mitochon- 
drial 
AcylCoA DH, short-ch 
specific 
AcylCoA DH, medium-ch 
specific 
AcylCoA DH, long-ch spe- 
cific 
Glucose 6-phosphate DH 
Glutamate DH 
Glyceraldehyde 3-phos- 
phate DH 
3/?-Hydroxy-5-ene steroid 
DHI 
3/I-Hydroxy-5-ene steroid 
DH II 
1 l/%Hydroxysteroid DH 
Lactate DH A 
Lactate DH C 
NAD(P)H DH 
NADH ubiquinone DH 
2-Oxoisovalerate DH, 
Ela subunit 
3-Oxo-5a-steroid 4-DH 
Pyruvate DH, El a subunit 
Sorbitol DH 
315 
(170) 
373 
(72) 
500 
500 
388 
396 
400 
514 
505 
334 
372 
372 
291 
331 
331 
273 
217 
401 
258 
361 
356 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
2 
0 
1 
4 
0 
1 
0 
0 
1 
3 
0 
1 
67 18 
(37) (22) 
21 6 
(11) 
86 
(15) 
17 
18 4 
32 8 
46 12 
53 13 
33 6 
10 2 
21 6 
103 28 
108 29 
72 25 
19 6 
91 27 
40 15 
13 6 
19 5 
103 40 
I 2 
62 17 
DH, dehydrogenase; ch, chain. Data from [7,8]. Alcohol DH of classes 
II and IV structures are still incomplete [8], as denoted by fragment 
designations and by values within parentheses. For glyceraldehyde 
3-phosphate DH and NAD(P) DH, two different forms have been 
reported for the human enzymes; the one most similar to the rat 
enzyme structure is the one used in each case. For enzyme pairs where 
the subunits differ in size between the species, the length given denotes 
the longer subunit as indicated in the Methods section. Number of 
differences includes gaps, whereas per cent differences is given relative 
to the number of positions in the longest polypeptide within each pair. 
Oxoisovalerate DH and pyruvate DH are multi-chain enzymes, where 
the El components have different functions, and in the former case 
is a decarboxylase component, but still listed. 3-oxo-5a-steroid 4-DH 
is the same as steroid Sa-reductase. 
A variable pattern constitutes the third type. It exhib- 
its variabilities well above the 10% level and includes 
most of the proteases/antiproteases, but also many pep- 
tide hormones and dehydrogenases. Although many 
proteases/antiproteases frequently have a size range in 
between those typical of the dehydrogenases (often 
larger) and peptide hormones (smaller), most proteases/ 
antiproteases fall outside the pattern typical of the latter 
two groups, compatible with few or variable functional 
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Table II 
Characterized structural differences between corresponding forms of 
human/rat peptide hormones 
Protein Length Gaps Differences 
(residues) (posi- 
tions) (number) (per cent) 
- 
ACTH 
&Lipotropin 
Angiotensin 
Bradykinin 
Calcitonin 
Cbolecystokinin-33 
Corticotropin RF 
Erythropoietin 
Gastin 
Growth hormone 
Growth hormone RF 
Glucagon 
Inhibin, a-chain 
Inhibin, /IA-chain 
Insulin, A-chain 
Insulin, B-chain 
Insulin, C-chain 
lslet amyloid pol~t~de 
Luteotropic hormone RH 
LH, &chain 
FSH, &chain 
TSH, @chain 
Glycopeptide hormone, 
cc-chain 
Thyrotropin RH 
Oxytocin 
Vasopressin 
Melanin concentrating 
hormone 
Neuropeptide Y 
Neurot~sin-reIated 
peptide 
Pancreatic hormone 
Parathyroid hormone 
Pamthyroid hormone- 
related protein 
Peptide YY 
Prolactin 
Relaxin. A-chain 
Relaxin. B-chain 
Secretin 
Somatostatin 
Thyroglobulin (fragment) 
Transthyretin 
Vasoactive internal 
peptide (VIP) 
39 0 
71 0 
10 0 
9 0 
32 0 
33 0 
41 0 
166 0 
17 0 
191 3 
44 1 
29 0 
134 1 
116 0 
21 0 
30 0 
31 0 
37 0 
10 0 
121 6 
111 1 
112 0 
96 
3 
9 
9 
19 
36 
9 
36 
84 
141 
36 
199 
24 
35 
27 
28 
967 
127 
28 
4 
0 
0 
0 
0 
0 
0 
0 
0 
4 
0 
2 
1 
2 
0 
0 
3 
0 
0 
2 
22 
0 
4 
3 
0 
29 
3 
66 
15 
0 
26 
0 
i 
; 
z 
39 
12 
10 
5 
31 
0 
0 
6 
9 
0 
17 
18 
35 
34 
0 
19 
0 
5 
10 
29 
16 
0 
32 
11 
9 
26 
1: 
0 
27 
0 
0 
0 
0 
0 
0 
0 
I fl 
8 22 
23 27 
18 13 
2 6 
74 37 
11 46 
22 63 
3 11 
0 0 
248 26 
22 17 
0 0 
RF, reieasing factor; RH, releasing hormone; P, protein. Two reports 
exist of rat insulin (parts A, B and C), rat gtycopeptide hormone 
(a-chain), and human relaxin (A and B chains). In all cases, the 
structure used is the one giving highest similarity. Thyroglobin, 
transthyretin, islet amyloid polypeptide and some of the small peptides 
are not hormones, but included because of their functional roles. 
/?-Lipotropins have an l&residue difference N-terminally that is not 
included above. Reports also exist for placental actogens but are not 
included since alignments are difficult, suggesting that the species 
variants represent non-corresponding forms. Data from [7J 
Table III 
Characterized structural diierences between corresponding forms of 
human/rat proteases and antiproteases 
Protein Length Gaps Differences 
(residues) (posi- 
tions) (number) (per cent) 
Acrosin 274 
Amyloid A4 (Nexin II) 753 
~*-~ti~sin 394 
Cathepsin B 268 
Cathepsin D 348 
Cathepsin E (fragment) (52) 
Cathepsin H 220 
Cathepsin L 221 
Chymase 227 
Chymotrypsin B, all chains 230 
Coagulation f IX, H-ch (fr) 227 
Complement C3, u-chain 993 
Complement C3, B-chain 645 
Cystatin a 103 
Cystatin fi 98 
Cystatin C 120 
Cystatin s 121 
Dipeptidyl peptidese IV (s) 731 
Elastase 2 241 
Furin 687 
Glia-derived nexin (Nexin I) 379 
Haptoglobin, a-chain 
Haptoglobin, B-chain 
Glandular kallikrein 
Plasma kallikrein, 
heavy-chain 
Plasma kallikrein, 
light-chain 
Cystatin-like pep from 
kininogens 
~~-M~oglob~in 
Nemoendocrine 
convertase 1 
Neuroendocrlne 
convertase 2 
Pancreatic seeretory 
trypsin inh 1 
Pepsin G (Gastricsin) 
Plasminogen activator 
inh-1 
Plasminogen activator 
inh-2 
Renin 
Thrombin 
Tissue pl~rn~nog~ 
activator 
Trypsin 1 
Trypsin 2 
Trypsin 3 
Urokinase 
83 
245 
237 
371 
248 
362 
1451 
643 
529 
56 
330 
379 
416 
340 
295 
530 
224 
224 
223 
413 
1 
0 
7 
0 
5 
0 
0 
3 
1 
0 
0 
1 
3 
7 
0 
0 
3 
3 
0 
I 
1 
0 
0 
1 
0 
0 
0 
I2 
1 
0 
0 
1 
0 
1 
4 
1 
2 
1 
1 
2 
2 
66 
22 
124 
45 
($ 
49 
89 
33 
35 
205 
153 
49 
21 
33 
82 
114 
39 
36 
57 
22 
46 
91 
24 
3 
31 
17 
(::, 
15 
22 
39 
14 
15 
21 
24 
48 
21 
27 
68 
16 
16 
5 
15 
27 
19 
41 
107 29 
50 20 
134 
389 
37 
27 
46 7 
17 3 
21 38 
82 25 
12 19 
114 27 
114 34 
36 12 
94 I8 
50 22 
47 21 
57 26 
117 28 
For the 2- and 3-chain proteases where special chain desilplations are 
not given, the entries denote the structures comprising the mature 
chains (plus the short activation peptides when the chains are not 
directly joined before cleavage). Values within parentheses indicate 
incomplete structures as in Table I. For glandular kallikrein, two 
human and three rat structures exist, for elastase 2 and pancreatic 
secretory trypsin inhibitor, other reports also exist. In all three cases, 
the pairs of most similar ~rn~rnatio~ have been used. Data from f7f; 
F, factor; H-ch, heavy chain; fr, fragment; s, soluble; pep, peptides; 
inb, inhibitor. 
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Fig. 1. Distribution of human/rat species variations between characterized protein pairs regarding dehydrogenases (DH, top), peptide hormones 
(PH, middle), and proteases/antiproteases (PIAP, bottom). Data from Tables I-III. 
interactions in the hydrolase reaction. The variability 
can demonstrate a continuity to very high levels of dif- 
ference, in the extreme cases above 50% between corre- 
sponding human and rat proteins (Fig. 1). 
Obviously, one factor regulating all patterns is size. 
In addition, the correlation with functional properties 
is apparent. Small molecules in binding interactions are 
strictly conserved (Fig. 1, middle line), whereas large 
molecules in hydrolytic reactions can exhibit considera- 
ble variation (Fig. 1, bottom line). The three largest 
proteins, a,-macroglobulin (Table III), complement C3 
(Table III) and thyroglobulin (Table II), all have varia- 
ble structures, with over 20% pairwise residue differ- 
ences. Similarly, both large and small polypeptides (de- 
hydrogenases and peptide hormones, respectively) dem- 
onstrate a high proportion of ‘constant’ proteins, ap- 
parently reflecting the ‘background level’ of multiple 
interactions. 
In the case of dehydrogenases, two variability pat- 
terns, constant and variable, have been noticed [6], but 
at that stage it was unclear which was the common 
alternative. We can now see that the constant pattern 
appears to be the one with many representatives centred 
at about the same value (6%, Fig. l), and thus the one 
most characteristic for that size and type of enzymatic 
reaction. Nevertheless, also the variable dehydrogenase 
type is still matched by the variabilities of the other 
proteins, and does therefore not indicate extraordinary 
circumstances, only less stringency than for the forms 
at the background level. It may be significant that 
among the dehydrogenases, class I alcohol dehydroge- 
nase is the one variable. It is of more recent origin than 
class III alcohol dehydrogenase [9], with an ethanol 
12 
dehydrogenase activity that has repeated origins [lo] 
and with several characterized isozyme sets, whereas the 
more constant class III alcohol dehydrogenase (consti- 
tuting glutathione-dependent formaldehyde dehydroge- 
nase [l 11) is of old origin and has unaltered functional 
properties. Apparently, a correlation with isozyme mul- 
tiplicity, substrate spread, metabolic function, or time 
since divergence may exist. 
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